Edward Rudnic

Edward M. Rudnic 78, M.S. 82, Ph.D. 83 (Pharmacy) of Potomac, Md. is founder, former chairman, and CEO of MiddleBrook Pharmaceuticals. He has more than 25 years of experience in the development and commercialization of a wide range of pharmaceutical products. His interest in delayed release, sustained release and continuous release oral drug delivery systems was developed at URI. Prior to founding Middlebrook, Rudnic directed U.S. research and development activities for Shire Pharmaceuticals, building a research team and product portfolio of Pharmavene, a drug delivery company that merged with Shire in 1997. The products he invented or co-invented, including Adderall XR have enjoyed more than $8 billion dollars in cumulative sales. Rudnic is the lead inventor or co-inventor on more than 80 U.S. and international patents.

Category:

Education

Tags:

• Pharmavene
• Adderall XR
• Adderall
• entrepreneur
• University of Rhode Island